STOCK TITAN

Cbdmd Inc - YCBD STOCK NEWS

Welcome to our dedicated page for Cbdmd news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on Cbdmd stock.

Company Overview

cbdMD, Inc. (YCBD) is a U.S.-based specialty company that produces and distributes premium hemp-derived cannabidiol (CBD) products combined with innovative functional mushroom supplements. Established in 2015 and headquartered in Charlotte, North Carolina, the company has cultivated a diverse portfolio that caters to both individual and pet wellness. Its key brands, including cbdMD, Paw CBD, and ATRx Labs, exemplify its dedication to natural health solutions backed by stringent quality standards and science-based research.

Business Model & Distribution

Operating in the dynamic wellness and cannabinoid industries, cbdMD, Inc. employs a multi-channel distribution strategy that drives revenue through a variety of platforms. The company leverages its flagship e-commerce website along with third-party online retail sites, wholesalers, and brick-and-mortar retailers. This extensive distribution network not only enhances market reach but also positions the business to address the increasing consumer demand for U.S.-produced, THC-free CBD and related wellness products.

Product Portfolio & Innovation

The product lineup of cbdMD, Inc. is comprehensive and varied, designed to meet a broad spectrum of consumer needs. The core offerings under the cbdMD brand include CBD tinctures, gummies, topicals, capsules, bath products, and sleep aids that have been formulated to provide relief and enhance overall well-being. The Paw CBD brand extends the company's expertise to pet wellness with veterinarian-formulated tinctures, chews, and topicals tailored for various pet health requirements.

In addition to its established CBD offerings, the company has diversified its product base with the ATRx Labs brand. This division focuses on functional mushroom supplements that harness the benefits of natural extraction and modern formulation techniques. These supplements are designed to support cognitive function, immune response, and overall health, integrating naturally derived ingredients to appeal to wellness enthusiasts who seek alternatives to traditional products.

Market Position & Industry Expertise

In an industry that demands both innovation and compliance, cbdMD, Inc. stands out through its commitment to product quality and scientific integrity. The company adheres to stringent manufacturing standards in line with Farm Bill regulations, ensuring all its products are THC-free and safe for consumption. It incorporates advanced extraction methods and clinical research to validate the efficacy of its formulations, thereby building a reputation grounded in transparency and trustworthiness.

Operational Strategy & Competitive Advantages

  • Multi-Channel Distribution: A vast network including its own e-commerce platform, third-party websites, and physical retail locations ensures extensive market penetration.
  • Science-Backed Formulations: Products are developed using rigorous research and clinical trial data that support claims of safety and effectiveness.
  • Innovative Product Development: Continuous investment in R&D allows the company to diversify its product portfolio and respond to emerging consumer trends.
  • Quality and Regulatory Compliance: The company’s commitment to producing THC-free, Farm Bill-compliant products is central to its value proposition.
  • Operational Efficiency: Strategic cost management and expense optimization reflect the company’s focus on enhancing its operational stability without compromising product quality.

Consumer & Investor Considerations

cbdMD, Inc. prioritizes consumer safety and product efficacy through stringent quality control measures and adherence to relevant regulatory standards. By blending traditional wellness practices with modern scientific advancements, the company delivers products that are not only innovative but also reliable. Investors and market analysts can view cbdMD, Inc. as a noteworthy example of a business that combines diversified revenue streams, a broad product portfolio, and a commitment to quality—and scientific validation—to build trust and stakeholder confidence.

Conclusion

Overall, cbdMD, Inc. is positioned as a comprehensive provider of premium CBD and functional wellness solutions. Through a robust operational framework, multi-channel distribution, and a steadfast commitment to quality and research, the company continues to build an enduring legacy in the competitive wellness market. Its systematic approach to innovation and operational integrity makes it a key subject of interest for in-depth investment research and market analysis.

Rhea-AI Summary
cbdMD, Inc. (NYSE American: YCBD) to Host Conference Call to Discuss Q4 and Full Year Fiscal 2023 Financial Results and Business Progress
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
conferences earnings
-
Rhea-AI Summary
cbdMD (NYSE American: YCBD) wins two bronze awards at the Best in Biz Awards for their CBD Freeze Roll-On and CBD PM Softgel Capsules - NSF Certified for Sport. The Freeze Roll-On provides quick relief from temporary muscle and joint discomfort, while the Softgel Capsules are the first CBD product to earn the NSF Certified for Sport certification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.63%
Tags
none
-
Rhea-AI Summary
cbdMD cancels vote on automatic conversion of Series A Preferred Stock due to insufficient proxies. Management to focus on business and explore strategic alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.04%
Tags
none
Rhea-AI Summary
cbdMD announces partnership with Club Sport Herediano, becoming the official sponsor of the FIFA-affiliated professional Costa Rican soccer team.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.32%
Tags
partnership
-
Rhea-AI Summary
cbdMD, Inc. adjourns Special Meeting of Shareholders to October 26, 2023 to solicit additional proxies for proposal to approve amendment to Certificate of Designation for Series A Preferred Stock. Board of Directors believes approval of proposal is in best interests of cbdMD and its shareholders. Shareholders encouraged to vote as soon as possible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
none
-
Rhea-AI Summary
cbdMD publishes safety data supporting safe upper dose of proprietary Broad Spectrum CBD blend
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.45%
Tags
none
Rhea-AI Summary
cbdMD reminds shareholders to vote ahead of the special meeting on September 22, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.5%
Tags
none
-
Rhea-AI Summary
cbdMD's Paw CBD brand receives 'Dog Hip & Joint Product of the Year' award for their Hip+Joint Soft Chews, enhancing overall wellbeing and supporting mobility in dogs. The chews are certified by NASC and come in three strengths. The award highlights cbdMD's commitment to innovative CBD products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
Rhea-AI Summary
cbdMD, Inc. suspends monthly cash dividend on Series A Preferred Stock to conserve cash for sales increase, product development, research, and profitability. Dividends will accumulate until sufficient working capital is restored. Suspension may impact capital raising. Shareholders to vote on automatic conversion of Series A Preferred to common stock on September 22, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
Rhea-AI Summary
cbdMD urges FDA for regulatory clarity on CBD products in response to Congressional RFI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.03%
Tags
none

FAQ

What is the current stock price of Cbdmd (YCBD)?

The current stock price of Cbdmd (YCBD) is $0.23 as of April 18, 2025.

What is the market cap of Cbdmd (YCBD)?

The market cap of Cbdmd (YCBD) is approximately 1.4M.

What type of products does cbdMD, Inc. offer?

cbdMD, Inc. offers a broad range of hemp-derived CBD products including tinctures, gummies, topicals, capsules, pet products, and functional mushroom supplements.

Which brands are operated by the company?

The company operates the cbdMD and Paw CBD brands for its CBD offerings and the ATRx Labs brand for its functional mushroom products.

How does the company distribute its products?

Products are distributed through the company’s e-commerce website, third-party online retailers, wholesalers, and traditional brick-and-mortar retail outlets across the United States.

What makes cbdMD, Inc. distinctive in the wellness market?

Its focus on science-backed product development, adherence to strict quality standards, and a diversified product portfolio in both CBD and functional mushroom segments distinguish cbdMD, Inc. in the competitive wellness market.

How does cbdMD ensure the safety and quality of its products?

The company follows rigorous manufacturing processes and quality control measures in compliance with Farm Bill regulations, ensuring that all products are THC-free and meet high safety standards.

What consumer segments does the company target?

cbdMD, Inc. targets wellness enthusiasts, pet owners, and consumers seeking natural health supplements and alternatives through both cannabinoid and functional mushroom products.

How is the company innovating in the CBD space?

Innovation is driven by continuous research and development efforts, including clinical trials and advanced formulation techniques that yield new products to meet diverse consumer health needs.

What advantages does the company have in the market?

Its multi-channel distribution, strong research foundation, commitment to quality, and ability to adapt to changing consumer trends provide cbdMD, Inc. with a competitive edge in the industry.
Cbdmd Inc

NYSE:YCBD

YCBD Rankings

YCBD Stock Data

1.37M
5.40M
13.79%
2.96%
7.74%
Drug Manufacturers - Specialty & Generic
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
CHARLOTTE